Pfizer Fact Sheet, Pfizer Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Pfizer Fact Sheet    (PFIZ)



Here is the latest financial fact sheet of Pfizer. For more details, see the Pfizer quarterly results and Pfizer share price and chart. For a sector overview, read our pharmaceuticals sector report.

PFIZER Price History

Price Rs 5,215.3
Mkt Cap Rs m 238,598
Vol '000 8.3
P/E X 47.7
P/CF X 47.7
EPS (TTM) Rs 109.3
% ch % -1.2
No. of shares m 45.75
% ch week % -2.2
% ch 1-mth % 1.6
% ch 12-mth % 18.2
52 week H/L Rs 5,875.0/3,940.0
(As on May 17, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

PFIZER Financials

No. of Mths
Year Ending
12
Mar-15
12
Mar-16
12
Mar-17
12
Mar-18
12
Mar-19
5-Yr Chart
Click to enlarge
PFIZER EQUITY SHARE DATA
High Rs2,3252,7242,0552,3653,840 
Low Rs1,1751,6111,6511,6252,080 
Sales per share (Unadj.) Rs405.1439.9429.8430.3455.0 
Earnings per share (Unadj.) Rs15.366.773.678.793.8 
Diluted earnings per shareRs15.366.773.678.793.8 
Cash flow per share (Unadj.) Rs43.979.387.493.2109.4 
Dividends per share (Unadj.) Rs12.5015.0020.0020.0022.50 
Adj. dividends per shareRs12.5015.0020.0020.0022.50 
Dividend yield (eoy) %0.70.71.11.00.8 
Book value per share (Unadj.) Rs420.0472.9528.7586.5658.2 
Adj. book value per shareRs420.0472.9528.7586.5658.2 
Shares outstanding (eoy) m45.7545.7545.7545.7545.75 
Bonus / Rights / Conversions  A---- 
Price / Sales ratio x4.34.94.34.66.5 
Avg P/E ratio x114.732.525.225.331.6 
P/CF ratio (eoy) x39.927.321.221.427.1 
Price / Book Value ratio x4.24.63.53.44.5 
Dividend payout %81.922.527.225.424.0 
Avg Mkt Cap Rs m80,06399,16384,77791,271135,420 
No. of employees `000NA2.92.82.62.6 
Total wages/salary Rs m2,3642,7733,0393,1433,238 
Avg. sales/employee Rs ThNM6,965.56,925.97,484.87,911.4 
Avg. wages/employee Rs ThNM960.01,070.41,195.01,230.9 
Avg. net profit/employee Rs ThNM1,055.71,186.31,369.11,630.7 
PFIZER INCOME DATA
Net Sales Rs m18,53320,12319,66319,68520,815 
Other income Rs m6748701,0121,1431,674 
Total revenues Rs m19,20720,99320,67420,82822,489 
Gross profit Rs m3,8304,3203,4915,0035,712 
Depreciation Rs m1,311579629663714 
Interest Rs m8510473 
Profit before tax Rs m3,1854,6053,8645,4796,599 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m-1,110991,30400 
Tax Rs m1,3771,6541,8011,8782,309 
Profit after tax Rs m6983,0503,3683,6014,291 
Gross profit margin %20.721.517.825.427.4 
Effective tax rate %43.235.946.634.335.0 
Net profit margin %3.815.217.118.320.6 
PFIZER BALANCE SHEET DATA
Current assets Rs m12,50616,32520,51324,16727,167 
Current liabilities Rs m5,3966,5847,7979,5448,917 
Net working cap to sales %38.448.464.774.387.7 
Current ratio x2.32.52.62.53.0 
Inventory Days Days7665605568 
Debtors Days Days3226202930 
Net fixed assets Rs m9,9969,6469,1759,5148,862 
Share capital Rs m458458458458458 
"Free" reserves Rs m18,75821,17823,73126,37529,656 
Net worth Rs m19,21521,63524,18926,83230,113 
Long term debt Rs m2525252525 
Total assets Rs m25,43428,88132,61036,90039,400 
Interest coverage x414.6886.7403.51,305.591.5 
Debt to equity ratio x00000 
Sales to assets ratio x0.70.70.60.50.5 
Return on assets %2.810.610.49.811.1 
Return on equity %3.614.113.913.414.2 
Return on capital %10.821.721.420.422.1 
Exports to sales %0.10.1000 
Imports to sales %23.117.5000 
Exports (fob) Rs m912000 
Imports (cif) Rs m4,2743,526000 
Fx inflow Rs m117526322428 
Fx outflow Rs m4,3831404,0671,489786 
Net fx Rs m-4,266-88-4,004-1,466-358 
PFIZER CASH FLOW
From Operations Rs m 1,135 3,455 3,288 3,318 978 
From Investments Rs m -888 -7,009 -2,496 -2,383 351 
From Financial Activity Rs m -14 -619 -826 -1,104 -1,099 
Net Cashflow Rs m 233 -4,174 -35 -169 231 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 0.0%
Foreign collaborators 63.9%
Indian inst/Mut Fund 7.5%
FIIs 4.9%
ADR/GDR 0.0%
Free float 23.7%
Shareholders 85,207
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Pfizer Centre, Patel Estate, S. V. Road, Jogeshwari (W), Mumbai - 400 102
E-MAIL prajeet.nair@pfizer.com WEB www.pfizerindia.com
TELEPHONE (022) 6693 2000 FAX (022) 2678 4569
SECTOR PHARMACEUTICALS GROUP M N C
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR B S R & Co. LLP
CHM: R. A. Shah COMP SEC: Prajeet Nair YEAR OF INC: 1950 BSE CODE: 500680 FV (Rs): 10 DIV YIELD (%): 0.4

Read: PFIZER 2017-18 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   WOCKHARDT  TORRENT PHARMA  NOVARTIS  ALEMBIC PHARMA  SUVEN LIFE SCIENCES  

Compare PFIZER With:   WOCKHARDT  TORRENT PHARMA  NOVARTIS  ALEMBIC PHARMA  SUVEN LIFE SCIENCES  

Compare PFIZER With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  




Today's Market

4 Reasons Why Sensex Surged 848 Points Today(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Views on news

PFIZER Announces Quarterly Results (3QFY21); Net Profit Up 1.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, PFIZER has posted a net profit of Rs 1 bn (up 1.6% YoY). Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY21); Net Profit Down 14.8% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, PFIZER has posted a net profit of Rs 1 bn (down 14.8% YoY). Sales on the other hand came in at Rs 6 bn (up 5.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

Is Intraday Trading For You? (Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK PFIZER

MORE ON PFIZER

PFIZER - ALEMBIC COMPARISON

COMPARE PFIZER WITH

MARKET STATS